CC-115 is a dual inhibitor of DNA-dependent protein kinase and mammalian target of rapamycin, with potential antineoplastic activity.
For research use only. We do not sell to patients.
| Name | CC-115 |
|---|---|
| Iupac Chemical Name | 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one |
| Synonyms | CC115 ; CC 115 |
| Molecular Formula | C16H16N8O |
| Molecular Weight | 336.14 |
| Smile | O=C1CNC2=NC=C(C3=CC=C(C4=NC=NN4)N=C3C)N=C2N1CC |
| InChiKey | GMYLVKUGJMYTFB-UHFFFAOYSA-N |
| InChi | InChI=1S/C16H16N8O/c1-3-24-13(25)7-18-15-16(24)22-12(6-17-15)10-4-5-11(21-9(10)2)14-19-8-20-23-14/h4-6,8H,3,7H2,1-2H3,(H,17,18)(H,19,20,23) |
| CAS Number | 1228013-15-7 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |